Coldstream Capital Management Inc Verve Therapeutics, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 497 shares of VERV stock, worth $2,564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
497Holding current value
$2,564% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VERV
# of Institutions
197Shares Held
77.8MCall Options Held
90KPut Options Held
153K-
Alphabet Inc. Mountain View, CA12.3MShares$63.7 Million5.03% of portfolio
-
Bvf Inc San Francisco, CA6.9MShares$35.6 Million1.46% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$34.2 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$20.6 Million1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$20.4 Million0.0% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $309M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...